Article
Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
Circulation. Cardiovascular genetics - 1 Aug 2011
Trenk Dietmar, Hochholzer Willibald, Fromm Martin F, Zolk Oliver, Valina Christian M, Stratz Christian, Neumann Franz-Josef
Abstract excerpt
BACKGROUND: Recently published data indicate that the paraoxonase-1 (PON1) Q192R genotype-and not as previously shown activity of cytochrome P450 (CYP) 2C19-is the major determinant of metabolic bioactivation of clopidogrel and thereby variability of antiplatelet effect of clopidogrel. We sought to investigate whether the PON1 Q192R gene polymorphism affects platelet reactivity in patients undergoing elective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
